Blister Packaging Market in the US to Record 7.23% Y-O-Y Growth Rate in 2022 | Evolving Opportunity with Amcor Plc & AmerisourceBergen Corp.| Technavio
NEW YORK, May 16, 2022 /PRNewswire/ -- Blister Packaging Market in US Facts at a Glance-
Total Pages: 120
Companies: 10+ ? Including Amcor Plc, AmerisourceBergen Corp., Â Andex Industries, Inc, Carton Service Inc., Combined Technologies Inc., Constantia Flexibles Group GmbH, Deufol SE, Honeywell International Inc., KP Holding GmbH and Co. KG, Â Lafayette Industries, Omnicell Inc., Rohrer Corp., Sinclair & Rush Inc., Sonoco Products Co., SouthPackÂ, Tekni Plex Inc., The Dow Chemical Co., Walter Drake Inc., WestRock Co., and Winpak Ltd. Oy among others.
The Blister Packaging Market in US size is expected to increase by USD 18.32 billion from 2021 to 2026, with an accelerated CAGR of 9.19%. as per the latest market report by Technavio. The blister packaging market share growth in the US by the thermoforming segment will be significant for revenue generation. By adopting high barrier thermoforming, the blister packaging manufacturers can reduce the blister footprint, even in the case of packing big-size capsules or tablets. Thermoforming can reduce the blister footprint by up to 65% more than cold forming technology. Therefore, the waste disposal in thermoforming packaging is lower than cold forming packaging. This will drive the growth of the thermoforming segment during the forecast period.
Download Sample: for more additional information on the contribution of each segment
Vendor Insights-
The Blister Packaging Market in US is fragmented, and the vendors are deploying growth strategies such as focusing on product delivery through multiple distribution channels to compete in the market.
Amcor.com - The company offers Formpack cold form pharmaceutical blister packaging that provides an impermeable barrier to moisture, light, oxygen, extended shelf life, and long-term delamination resistance.
Amerisourcebergen.com - The company offers comprehensive unit dose products such as blister packaging that simplify scanning and support extended shelf life.
The cost benefits of blister packaging is one of the key drivers supporting the blister packaging market growth in the US.
The cost of over-the-counter drug packaging is estimated to be higher than the prescribed pharmaceutical products.
The pharmaceutical products are commonly packed in glass bottles, plastic bottles, and blister packs. Among all the three types of packaging, blister packaging is more economical throughout the supply chain of a pharmaceutical product.
The blisters packaging is more sustainable, as it creates fewer landfills compared with plastic and bottle packages.
The amount of energy and carbon emission during blister package manufacturing is lesser than in plastic and glass bottle manufacturing. These cost benefits of blister packaging are expected to influence the demand for blister packaging in the pharmaceutical industry in the US during the forecast period.
Blister Packaging Market in US Trend:
The emergence of contract packaging is one of the key blister packaging market trends in the US fueling the market growth.
Most of the contract manufacturers and packaging vendors are certified by the Food and Drug Administration (FDA), which maintains detailed standard operation procedures (SOP) and follows Good Manufacturing Practices (GMP).
The contract packaging companies offer services such as barcoding, a process required by the FDA, where all drugs manufactured for medical use should be encoded with national drug barcodes.
If some of the medicines go off-patent, the production of generic medicines increases, and pharmaceutical manufacturers function at a high level of productivity. It is also difficult for pharmaceutical manufacturers to invest in the RD of innovative and customized packaging. Hence, the demand for contract packaging increases as contract manufacturers has the required infrastructure and skilled expertise. This is driving the market growth.
Don't wait, Make a strategic approach & boost your business goals with our Blister Packaging Market in US Report - Buy Now!
Also, you can speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. For customization - Speak to our Analyst now!
Related Reports
The contract packaging market share is estimated to be valued at USD 17.29 billion by 2026, at an accelerating CAGR of 6.3%. Download a sample now!
The plastic packaging market share in Mexico is expected to increase by USD 7.81 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 13.26%. Download a sample now!
Blister Packaging Market In The US Scope
Report Coverage
Details
Page number
120
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Accelerate at a CAGR of almost 9.19%
Market growth 2022-2026
USD 18.32 billion
Market structure
Fragmented
YoY growth (%)
7.23
Regional analysis
US
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Amcor Plc, AmerisourceBergen Corp.,  Andex Industries, Inc, Carton Service Inc., Combined Technologies Inc., Constantia Flexibles Group GmbH, Deufol SE, Honeywell International Inc., KP Holding GmbH and Co. KG,  Lafayette Industries, Omnicell Inc., Rohrer Corp., Sinclair & Rush Inc., Sonoco Products Co., SouthPack , Tekni Plex Inc., The Dow Chemical Co., Walter Drake Inc., WestRock Co., and Winpak Ltd.
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of Contents:
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Country Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market Segmentation by Technology
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Component
Exhibit 06: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 07: Parent market
Exhibit 08: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 09: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 10: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 11: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 12: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 13: Chart on US: Year-over-year growth 2021-2026 (%)
Exhibit 14: Data Table on US: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 15: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 16: Chart on Bargaining power of buyers ? Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 17: Bargaining power of suppliers ? Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 18: Threat of new entrants ? Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 19: Threat of substitutes ? Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 20: Threat of rivalry ? Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 21: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Technology
5.1 Market segments
Exhibit 22: Chart on Technology - Market share 2021-2026 (%)
Exhibit 23: Data Table on Technology - Market share 2021-2026 (%)
5.2 Comparison by Technology
Exhibit 24: Chart on Comparison by Technology
Exhibit 25: Data Table on Comparison by Technology
5.3 Thermoforming - Market size and forecast 2021-2026
Exhibit 26: Chart on Thermoforming - Market size and forecast 2021-2026 ($ million)
Exhibit 27: Data Table on Thermoforming - Market size and forecast 2021-2026 ($ million)
Exhibit 28: Chart on Thermoforming - Year-over-year growth 2021-2026 (%)
Exhibit 29: Data Table on Thermoforming - Year-over-year growth 2021-2026 (%)
5.4 Cold forming - Market size and forecast 2021-2026
Exhibit 30: Chart on Cold forming - Market size and forecast 2021-2026 ($ million)
Exhibit 31: Data Table on Cold forming - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Honeywell International Inc. - Overview
Exhibit 65: Honeywell International Inc. - Business segments
Exhibit 66: Honeywell International Inc. - Key offerings
Exhibit 67: Honeywell International Inc. - Segment focus
10.6 KP Holding GmbH and Co. KG
Exhibit 68: KP Holding GmbH and Co. KG - Overview
Exhibit 69: KP Holding GmbH and Co. KG - Product / Service
Exhibit 70: KP Holding GmbH and Co. KG - Key offerings
10.7 Omnicell Inc.
Exhibit 71: Omnicell Inc. - Overview
Exhibit 72: Omnicell Inc. - Business segments
Exhibit 73: Omnicell Inc. - Key offerings
Exhibit 74: Omnicell Inc. - Segment focus
10.8 Sonoco Products Co.
Exhibit 75: Sonoco Products Co. - Overview
Exhibit 76: Sonoco Products Co. - Business segments
Exhibit 77: Sonoco Products Co. - Key offerings
Exhibit 78: Sonoco Products Co. - Segment focus
10.9 Tekni Plex Inc.
Exhibit 79: Tekni Plex Inc. - Overview
Exhibit 80: Tekni Plex Inc. - Product / Service
Exhibit 81: Tekni Plex Inc. - Key offerings
10.10 The Dow Chemical Co.
Exhibit 82: The Dow Chemical Co. - Overview
Exhibit 83: The Dow Chemical Co. - Business segments
Exhibit 84: The Dow Chemical Co. - Key news
Exhibit 85: The Dow Chemical Co. - Key offerings
Exhibit 86: The Dow Chemical Co. - Segment focus
10.11 WestRock Co.
Exhibit 87: WestRock Co. - Overview
Exhibit 88: WestRock Co. - Business segments
Exhibit 89: WestRock Co. - Key news
Exhibit 90: WestRock Co. - Key offerings
Exhibit 91: WestRock Co. - Segment focus
10.12 Winpak Ltd.
Exhibit 92: Winpak Ltd. - Overview
Exhibit 93: Winpak Ltd. - Business segments
Exhibit 94: Winpak Ltd. - Key offerings
Exhibit 95: Winpak Ltd. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 96: Inclusions checklist
Exhibit 97: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 98: Currency conversion rates for US$
11.4 Research methodology
Exhibit 99: Research methodology
Exhibit 100: Validation techniques employed for market sizing
Exhibit 101: Information sources
11.5 List of abbreviations
Exhibit 102: List of abbreviations
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Sandra M. Swain, M.D., to its Board of Directors. Dr. Swain has over 30 years of oncology...
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV.
Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...